The brightest object in the universe is a black hole that eats a star a day 
Genetic diseases: How scientists are working to make DNA repair (almost) a piece of cake 
The mystery of consciousness shows there may be a limit to what science alone can achieve 
Alpha, beta, theta: what are brain states and brain waves? And can we control them? 
Six space missions to look forward to in 2024 
Spacesuits need a major upgrade for the next phase of exploration 
Why now is the time to address humanity’s impact on the moon 
Customizing mRNA is easy, and that's what makes it the next frontier for personalized medicine − a molecular biologist explains 
The rising flood of space junk is a risk to us on Earth – and governments are on the hook 
Could a telescope ever see the beginning of time? An astronomer explains 
Why some people don't trust science – and how to change their minds 
Orbital resonance − the striking gravitational dance done by planets with aligning orbits 
Larger and more frequent solar storms will make for potential disruptions and spectacular auroras on Earth 
Dark energy is one of the biggest puzzles in science and we're now a step closer to understanding it 
Tatahouine: 'Star Wars meteorite' sheds light on the early Solar System 
Consuming a pill or being injected with a drug to enhance cognitive functions is a staple in sci-fi culture that many have been trying to bring to reality for decades. Proponents of the concept of nootropics or so-called “smart drugs” believe that humans can gain an intellectual edge with the right pills. Thanks to research in cognitive disorders, the industry could see a huge boost in research advancements.
In the most recent report by Research and Markets on the nootropics industry, the industry is projected to go from being worth $1.3 billion in 2015 to $6 billion in 2024. A respectable level of growth, but not spectacular by any means.
One of the biggest chains holding back the explosion of popularity of brain-enhancing drugs is the lack of research into the field. Many of the pills or food supplements found in the market are either not supported by scientists or are marketed with non-definitive terms.
As Futurism notes, however, the ongoing research into degenerative brain diseases could change this. One example is the research being done by a professor of psychiatry and molecular medicine at Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Todd Lencz.
In the paper published in Cell recently, the researchers detailed how they might have discovered certain secrets involving genetic information that affect cognitive performance. Their findings could have a huge impact on the development of more effective nootropics, although Lencz himself is not convinced.
“It is important to emphasize that our target is enhancing cognitive ability in patients with neurocognitive disorders. If our research is successful over the long-term, we might be able to help millions of such patients in the decades to come,” Lencz told Futurism. “However, it is unlikely that these approaches will have a noticeable effect on the daily lives of healthy people, at least in the foreseeable future.”
As a peer-reviewed study, however, what Lencz and his team uncovered could lead to even more breakthroughs in creating brain-enhancing drugs. With the lack of funding, researchers in the field have no choice but to rely on data from others.
